The University of Chicago Header Logo

Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer.

Elevated Eosinophil Count Following Pembrolizumab Treatment for Non-Small Cell Lung Cancer. Cureus. 2021 Jul; 13(7):e16266.

View in: PubMed